ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 82 filers reported holding ENZO BIOCHEM INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $144,000 | +132.3% | 64,109 | +161.2% | 0.00% | 0.0% |
| Q1 2020 | $62,000 | +55.0% | 24,546 | +119.7% | 0.00% | – |
| Q3 2019 | $40,000 | -82.6% | 11,175 | -46.3% | 0.00% | -100.0% |
| Q2 2017 | $230,000 | -16.1% | 20,820 | -36.4% | 0.00% | 0.0% |
| Q1 2017 | $274,000 | +27.4% | 32,720 | +5.5% | 0.00% | +100.0% |
| Q4 2016 | $215,000 | +8.0% | 31,020 | -20.7% | 0.00% | 0.0% |
| Q3 2016 | $199,000 | -42.8% | 39,120 | -32.8% | 0.00% | -66.7% |
| Q2 2016 | $348,000 | -36.7% | 58,220 | -51.8% | 0.00% | -25.0% |
| Q1 2016 | $550,000 | -11.6% | 120,820 | -12.6% | 0.00% | -20.0% |
| Q4 2015 | $622,000 | +71.3% | 138,220 | +20.8% | 0.01% | +66.7% |
| Q3 2015 | $363,000 | +29.6% | 114,420 | +23.9% | 0.00% | 0.0% |
| Q2 2015 | $280,000 | +3.7% | 92,320 | +0.8% | 0.00% | +50.0% |
| Q1 2015 | $270,000 | -23.5% | 91,620 | +15.2% | 0.00% | -33.3% |
| Q4 2014 | $353,000 | -6.6% | 79,520 | +8.3% | 0.00% | 0.0% |
| Q3 2014 | $378,000 | – | 73,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |